Glaukos Corp Files 8-K

Ticker: GKOS · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1192448

Sentiment: neutral

Topics: sec-filing, regulation-fd, financials

Related Tickers: GKOS

TL;DR

Glaukos filed an 8-K on Jan 14, 2025. Check for updates.

AI Summary

Glaukos Corporation filed an 8-K on January 14, 2025, reporting under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at One Glaukos Way, Aliso Viejo, California, 92656, and its telephone number. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates Glaukos Corporation is providing updated information to the SEC, which could include material disclosures relevant to investors.

Risk Assessment

Risk Level: low — The provided excerpt is a routine filing and does not contain information that suggests immediate or significant risk.

Key Players & Entities

FAQ

What specific information is being disclosed in this 8-K filing?

The provided excerpt indicates the filing is for Regulation FD Disclosure and Financial Statements and Exhibits, with the earliest event reported on January 14, 2025. Specific details of the disclosures are not included in this portion.

What is the primary business of Glaukos Corporation?

Glaukos Corporation is listed under the Standard Industrial Classification code 3841 for SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

When was Glaukos Corporation incorporated and in which state?

Glaukos Corporation was incorporated in Delaware.

What is the Commission File Number for Glaukos Corporation?

The Commission File Number for Glaukos Corporation is 001-37463.

What is the address of Glaukos Corporation's principal executive offices?

The principal executive offices of Glaukos Corporation are located at One Glaukos Way, Aliso Viejo, California, 92656.

Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-01-14 16:05:28

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Investor Presentation, dated January 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLAUKOS CORPORATION (Registrant) By: /s/ Alex R. Thurman Name: Alex R. Thurman Title: Senior Vice President & Chief Financial Officer Date: January 14, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing